|
Durk Pearson & Sandy Shaw’s®
Life Extension NewsTM
Volume 15 No.
2 • March-April 2012
Research and Development Costs for
Getting FDA Drug Approval Soar
Forbes Magazine’s Matthew Herper and Scott DeCarlo came up with new estimates of drug development costs by dividing pharmaceutical company’s research and development budgets by the number of approved drugs over 15 years. From their calculations, which are said to build off of figures from Bernard Munos at the InnoThink Center for Research in Biomedical Innovation, the pharma company AstraZeneca spent $12 billion on R&D for every new approved drug, while Amgen spent $3.7 billion. Is it any wonder that new medications cost a great deal, that pharmaceutical companies try to get in bed with (e.g., bribe) the regulatory authorities and lawmakers, and that so few new treatments ever get to market?
|